220 related articles for article (PubMed ID: 27183828)
21. Pompe disease: An Indian series diagnosed on muscle biopsy by ultrastructural characterization.
Kakkar A; Sharma MC; Nambirajan A; Gulati S; Bhatia R; Suri V; Sarkar C
Ultrastruct Pathol; 2018; 42(3):211-219. PubMed ID: 29565761
[TBL] [Abstract][Full Text] [Related]
22. Cardiac response to enzyme replacement therapy in infantile Pompe disease with severe hypertrophic cardiomyopathy.
Avula S; Nguyen TM; Marble M; Lilje C
Echocardiography; 2017 Apr; 34(4):621-624. PubMed ID: 28266734
[TBL] [Abstract][Full Text] [Related]
23. Very Early Treatment for Infantile-Onset Pompe Disease Contributes to Better Outcomes.
Yang CF; Yang CC; Liao HC; Huang LY; Chiang CC; Ho HC; Lai CJ; Chu TH; Yang TF; Hsu TR; Soong WJ; Niu DM
J Pediatr; 2016 Feb; 169():174-80.e1. PubMed ID: 26685070
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes of very early treated infantile-onset Pompe disease with short-term steroid premedication: experiences from a nationwide newborn screening programme.
Yang CF; Liao TE; Chu YL; Chen LZ; Huang LY; Yang TF; Ho HC; Kao SM; Niu DM
J Med Genet; 2023 May; 60(5):430-439. PubMed ID: 36137614
[TBL] [Abstract][Full Text] [Related]
25. Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function.
Figueroa-Bonaparte S; Segovia S; Llauger J; Belmonte I; Pedrosa I; Alejaldre A; Mayos M; Suárez-Cuartín G; Gallardo E; Illa I; Díaz-Manera J;
PLoS One; 2016; 11(10):e0163493. PubMed ID: 27711114
[TBL] [Abstract][Full Text] [Related]
26. Muscle ultrasound: A useful tool in newborn screening for infantile onset pompe disease.
Hwang HE; Hsu TR; Lee YH; Wang HK; Chiou HJ; Niu DM
Medicine (Baltimore); 2017 Nov; 96(44):e8415. PubMed ID: 29095275
[TBL] [Abstract][Full Text] [Related]
27. A new assay for fast, reliable CRIM status determination in infantile-onset Pompe disease.
Wang Z; Okamoto P; Keutzer J
Mol Genet Metab; 2014 Feb; 111(2):92-100. PubMed ID: 24044919
[TBL] [Abstract][Full Text] [Related]
28. Evaluating brain white matter hyperintensity, IQ scores, and plasma neurofilament light chain concentration in early-treated patients with infantile-onset Pompe disease.
Hsu YK; Chien YH; Shinn-Forng Peng S; Hwu WL; Lee WT; Lee NC; Po-Yu Huang E; Weng WC
Genet Med; 2023 Jan; 25(1):27-36. PubMed ID: 36399131
[TBL] [Abstract][Full Text] [Related]
29. Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease.
Chien YH; Hwu WL; Lee NC; Tsai FJ; Koeberl DD; Tsai WH; Chiu PC; Chang CL
Mol Genet Metab Rep; 2017 Jun; 11():31-35. PubMed ID: 28480166
[TBL] [Abstract][Full Text] [Related]
30. [A case of Pompe disease treated with acid alpha-glucosidase].
Kapica-Topczewska K; Tarasiuk J; Kułakowska A; Drozdowski W
Neurol Neurochir Pol; 2008; 42(4):353-7. PubMed ID: 18975241
[TBL] [Abstract][Full Text] [Related]
31. Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques.
Young SP; Piraud M; Goldstein JL; Zhang H; Rehder C; Laforet P; Kishnani PS; Millington DS; Bashir MR; Bali DS
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):50-8. PubMed ID: 22252961
[TBL] [Abstract][Full Text] [Related]
32. [Thoracoabdominal muscle involvement in anti-PL-7 myopathy revealed by whole-body magnetic resonance imaging].
Matsuda N; Sato S; Nemoto A; Kubo H; Kobayashi S; Ugawa Y
Rinsho Shinkeigaku; 2018 Nov; 58(11):692-695. PubMed ID: 30369527
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease.
Kishnani PS; Corzo D; Nicolino M; Byrne B; Mandel H; Hwu WL; Leslie N; Levine J; Spencer C; McDonald M; Li J; Dumontier J; Halberthal M; Chien YH; Hopkin R; Vijayaraghavan S; Gruskin D; Bartholomew D; van der Ploeg A; Clancy JP; Parini R; Morin G; Beck M; De la Gastine GS; Jokic M; Thurberg B; Richards S; Bali D; Davison M; Worden MA; Chen YT; Wraith JE
Neurology; 2007 Jan; 68(2):99-109. PubMed ID: 17151339
[TBL] [Abstract][Full Text] [Related]
34. Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients.
Bernstein DL; Bialer MG; Mehta L; Desnick RJ
Mol Genet Metab; 2010; 101(2-3):130-3. PubMed ID: 20638881
[TBL] [Abstract][Full Text] [Related]
35. A novel mutation of the GAA gene in a Finnish late-onset Pompe disease patient: clinical phenotype and follow-up with enzyme replacement therapy.
Korpela MP; Paetau A; Löfberg MI; Timonen MH; Lamminen AE; Kiuru-Enari SM
Muscle Nerve; 2009 Jul; 40(1):143-8. PubMed ID: 19472353
[TBL] [Abstract][Full Text] [Related]
36. Muscle ultrasound in classic infantile and adult Pompe disease: a useful screening tool in adults but not in infants.
Vill K; Schessl J; Teusch V; Schroeder S; Blaschek A; Schoser B; Müller-Felber W
Neuromuscul Disord; 2015 Feb; 25(2):120-6. PubMed ID: 25455803
[TBL] [Abstract][Full Text] [Related]
37. Reveglucosidase alfa (BMN 701), an IGF2-Tagged rhAcid α-Glucosidase, Improves Respiratory Functional Parameters in a Murine Model of Pompe Disease.
Peng J; Dalton J; Butt M; Tracy K; Kennedy D; Haroldsen P; Cahayag R; Zoog S; O'Neill CA; Tsuruda LS
J Pharmacol Exp Ther; 2017 Feb; 360(2):313-323. PubMed ID: 27856936
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease.
Orlikowski D; Pellegrini N; Prigent H; Laforêt P; Carlier R; Carlier P; Eymard B; Lofaso F; Annane D
Neuromuscul Disord; 2011 Jul; 21(7):477-82. PubMed ID: 21550241
[TBL] [Abstract][Full Text] [Related]
39. Effect of enzyme replacement therapy on isokinetic strength for all major muscle groups in four patients with Pompe disease-a long-term follow-up.
Andreassen CS; Schlütter JM; Vissing J; Andersen H
Mol Genet Metab; 2014 May; 112(1):40-3. PubMed ID: 24685124
[TBL] [Abstract][Full Text] [Related]
40. Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study.
Klinge L; Straub V; Neudorf U; Voit T
Neuropediatrics; 2005 Feb; 36(1):6-11. PubMed ID: 15776317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
